Business Combinations (Tables)

6 Months Ended

Mar. 29, 2025

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The purchase price was allocated to Gynesonics’ preliminary tangible and identifiable intangible assets and liabilities based on their preliminary estimated fair values as of January 2, 2025, as set forth below.


Cash		$	19.2
Accounts receivable		4.5
Inventory		7.2

Other assets		6.7
Accounts payable and accrued expenses		(21.1)

Identifiable intangible assets:
	Developed technology	140.8
	Trade names	4.0
	Customer relationship	1.3



Deferred income taxes, net		(12.9)
Goodwill		191.0
Purchase Price		$	340.7

The purchase price was allocated to Endomag’s preliminary tangible and identifiable intangible assets and liabilities based on their preliminary estimated fair values as of July 25, 2024, as set forth below.


Cash		$	16.2
Accounts receivable		5.5
Inventory		13.7

Other assets		7.0
Accounts payable and accrued expenses		(22.6)

Identifiable intangible assets:
	Developed technology	180.9
	Trade names	7.4
	Customer relationship	6.5
	In-process research and development	3.0


Deferred income taxes, net		(43.8)
Goodwill		140.1
Purchase Price		$	313.9